The FTSE 100 is beating America. It is not a bet on Britain.

A one-day fall of 0.31% in Britain's FTSE 100 is the kind of figure that leads the financial wires and tells you nothing. The surrounding facts tell you more. The index closed on August 26th at 10,878, about 1% below the all-time intraday high of 10,980 it set on July 30th. And for the past year and a half it has been doing something unfashionable: beating American stocks. Britain's blue-chip index rose 21.5% in 2025, outpacing the S&P 500, the Nasdaq and the Dow. It has beaten America's benchmarks only three times in a decade. Americans who own nothing but domestic index funds should pause: this is among the largest markets their default portfolio does not own, and it has been refusing to cooperate with the story told about where growth lives.

The reason the run is easy to misread is that the FTSE 100 is not really a bet on Britain. Roughly three-quarters of its members' earnings come from abroad. About a fifth of the market is miners and oil producers; healthcare and consumer staples are another fifth; global banks such as HSBC and defence names such as Rolls-Royce fill much of the rest. These are world-beating companies that happen to be listed in London, with little technology in sight — the same index dismissed for years as a museum of old-economy stalwarts. The index tracks oil, copper, banking margins, cigarettes and stout, not the British high street, not British productivity, not the mortgage market. That is why it can sit at records while Britain's inflation spiked to 3.3% in March on an energy shock. The flag is just the address.

It helps that the address was cheap and paid its way. At the start of 2026 the FTSE carried a forward price-earnings ratio near 13, against about 20 for the S&P 500. Its dividend yield is close to 3%, roughly triple the S&P's, which has fallen to barely 1%, near fifty-year lows. The cash is not cosmetic: companies in the index returned about £180bn to shareholders in 2025 through dividends, buybacks and takeovers, a pace expected to continue at roughly £130bn this year, the equivalent of 4.6% of the market's entire value. That is the definition of getting paid to wait. It also helped that 2025 was the year American money lost interest in its own market: after the tariff shock of April 2025 raised questions about the price of artificial intelligence, money rotated from crowded American growth to unloved value, and nobody was more unloved, or cheaper, than London.

Now the caution, in two parts. The recent leg of the rally is partly a war trade. Since the war in the Middle East began in late February, oil and defence have done well, and a Bank of England holding rates at 3.75% — markets put a near-even chance on a December rise — has fattened bank margins. Yet American shares have at times outrun the FTSE again since the war began; the index is no safe harbour, just a sector bet with a flag. And the honest long-run record is hostile. Britain has beaten America's benchmarks only three times in ten years. Cheap and high-yielding is what it is; the compounding was American.

Beneath the record index, the story grows stranger. London's main market listed 925 companies at the end of last year, down from more than 2,700 in the mid-1990s. The departures are not only the weak. This year Schroders, an asset manager whose sale ended two centuries of family ownership, agreed a £9.9bn takeover by Nuveen, an American firm owned by the teachers' insurer TIAA. Tate & Lyle, a food-ingredient maker, agreed a £2.7bn sale to Ingredion, an American rival. Do not blame takeovers alone: there were 25 firm offers for London-listed companies in the first half of 2026, below the pace of each of the past three years. The true disease is on the way in. Barely 23 companies floated in London in 2025, raising £2.1bn — a rebound from nothing, still a trickle. As Henrik Persson of Cavendish, a City advisory firm, argues, the problem is not that companies leave; it is that not enough good companies arrive.

Which is connected to the discount. A market that cannot replenish itself with new winners reshapes itself into a dividend machine for the ones that remain, and investors rationally demand a discount for that. Britain has spent a generation exporting the other half of the story: UK pension funds hold just 4.4% of their assets in British equities, down from more than half a quarter-century ago, among the lowest shares in the rich world. A country whose biggest institutional buyers stopped buying has been announcing itself cheap for years. The state has noticed. The Pension Schemes Act 2026, described as the most significant pensions law in a generation, gives the government a reserve power to require default pension funds to invest up to 10% of their assets in private markets and unlisted equity — private-equity stakes, infrastructure, firms that never floated — of which up to five points could be required to be British. Regulators guard the lever, with a test that it serve members' best interests, and it can be used only between 2028 and 2032. Combined with the consolidation of pension pots into funds of £25bn or more, the intent is to buy back a market that pensions abandoned.

Read the fine print before assuming this repairs the index. Most of the mandated money is aimed at unlisted companies — precisely the ones that chose not to list — so it may inflate the prices of private British firms without putting a bid under the FTSE 100 that an American can own in an ETF. The honest reading is that Britain is attempting to buy back its own market, slowly and on fiduciary tiptoe. The mechanism to watch is not the law's passage but whether the pension megafunds shift their equity allocations toward UK shares, because that is what would compress a discount that has outlived every bull market of the past decade. It is a reason the gap might close; not a promise that it will.

For an American, no round-trip ticket is required. The main US-listed fund for British large-caps, the iShares MSCI United Kingdom ETF, holds the familiar names — HSBC, Shell, AstraZeneca, Rolls-Royce, Unilever — for a fee of 0.5%. Its flows this year are a lesson in allocation as sentiment: roughly $620m net entered by late summer as retail chased the outperformance; about $340m left in the past month as the war-fuelled rally in American stocks lured that money back. Like the 0.31% move, the flows are feeling, not fact. And one further complication: the fund is unhedged, so dollar returns depend on the pound, which trades near $1.36.

So set the headline aside. A summer's 0.31% wiggle tells an investor nothing; the structure tells them what the trade is. It is a contrarian one: own the world's cheap, dividend-paying cyclicals at a discount to an American market feeding on its own concentration, take the currency exposure, and accept that a decent slice of recent returns rests on war. The variable that would actually change the arithmetic is not tomorrow's close but whether Britain's new pension giants, when they exist, do what the law intends. Until they do, the index can keep making records while the exchange drains — two different stories, and it pays to know which one you are buying.